American Heart Association Professional Education Committee. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific Statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008 Jun;51(6):1403-1419.
Uncontrolled and apparent treatment resistant hypertension in the US 1988–2008. Circulation 2011 Aug 30;124(9):1046-1058.
Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 1985 Mar;75(3):809-817.
Prevalence of optimal treatment regimens in patients with apparent treatment resistant hypertension in a community-based practice network. Hypertension 2013 Oct;62(4):691-697.
Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 2011 May;57(5):898-902.
Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med 2008 Nov 24;168(21):2340-2346.
Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertension 2005 Nov; 18(11):1422-1428.
Screening for high blood pressure in adults: US Preventive Services Task Force Recommendation Statement. Ann Intern Med 2015 Nov 17;163(10). DOI: 10.7326/P15-9036. Epub 2015 Oct 13.
Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 2006 May;47(5):846-853.
Automated office blood pressure measurement in primary care. Can Fam Physician 2014 Feb;60(2):127-132.
Beneficial effects of a dietary approaches to stop hypertension eating plan on features of the metabolic syndrome. Diabetes Care 2005 Dec;28(12):2823-2831.
Relationship between overnight rostral fluid shift and obstructive sleep apnea in drug-resistant hypertension. Hypertension 2010 Dec;56(6):1077-1082.
Spironolactone reduces severity of obstructive sleep apnea in patients with resistant hypertension: a preliminary report. J Hum Hypertens 2010 Aug;24(8):532-537. DOI: 10.1038/jhh.2009.96. Epub 2009 Dec 17.
Continuous positive airway pressure reduces blood pressure in patients with obstructive sleep apnea: a systematic review and meta-analysis with 1000 patients. J Hypertens 2014 Sep; 32(9):1762-1773.
Treatment resistant hypertension. Up To Date. Available at: (http://www.uptodate.com/contents/treatment-of-resistant-hypertension. Accessed on: 24 Aug 2015.
Predictors of hyperkalemia risk following hypertension control with aldosterone blockade. Am J Nephrol 2009;30(5):418-424.
Laragh's lessons in pathophysiology and clinical pearls for treating hypertension. Lesson XVI: How to choose the correct drug for each hypertensive patient using a plasma renin-based method and the volume-vasoconstriction analysis. Am J Hypertens 2001;14(6):491-503.
Renin-guided algorithm matches clinical hypertension specialist care in uncontrolled hypertension: a randomized-controlled clinical trial. Am J Hypertens 2009 Jul;22(7):792-801.
Canadian Hypertension Education Program. The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol 2014 May;30(5):485-501.
Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the dublin outcome study. Hypertension 2005 Jul;46(1):156-161.
Medication adherence: its importance in cardiovascular outcomes. Circulation 2009 Jun 16;119(23):3028-3035.
Home blood pressure management and improved blood pressure control: results from a randomized controlled trial. Arch Intern Med 2011 Jul 11;171(13):1173-1180.
Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation 2012 Apr 3;125(13):1635-1642.
Treating to New Targets Steering Committee and Investigators. Prevalence, predictors and outcomes in treatment-resistant hypertension in patients with coronary disease. Am J Med 2014 Jan;127(1):71-81.
Treatment resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the antihypertensive and lipid-lowering treatment to prevent heart attack (ALLHAT). Hypertension 2014 Nov;64(5):1012-1021.
Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality. J Am Soc Hypertens 2014 Jun;8(6):405-413.
Cardiovascular outcomes in hypertensive patients comparing single-agent therapy with combination therapy. J Hypertens 2012 Nov;30(11):2213-2222.
Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: a report from NHANES 1988–2010. Circulation 2013 Jul 2;128(1):29-41.
ASCOT investigators. Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk. J Hypertens 2011 Oct;29(10):2004-2013.
Anti-hypertensive effects of statins: a meta-analysis of prospective controlled studies. J Clin Hypertens (Greenwich) 2013 May; 15(5):310-320.
Seventh report of the Joint National Committee on Prevention. Detection, evaluation, and treatment of high blood pressure. Hypertension 2003 Dec;42(6):1206-1252.
